Thanks
@Ango-Roch for sharing, I'm thinking from here on in Mesoblast will do more and more of these promotional interviews, as we are approaching commercialisation.
What I like was "
That is how we would look at each of these disease states. If we succeed, we make a major impact. Obviously,manufacturing, regulatory and clinical trial design all come into it, and I think that Mesoblast has successfully navigated through all of those factors."
SI knows what he is doing.
The trials are all science, but the trial design is a lot of art.
SI has navigated the first one well. He has positioned Ryoncil as a narrow path solution. Once approved, then we can expand it's usage.
This makes it easier to assess and get approved.
Anyway, that's my main takeaway.
Now where are these announcements?
The US are swimming in money to deal with COVID-19 - two Trillion wasn't it?
GLTASHs
(20min delay)